TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Complete clinical clearance of hemangioma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of hemangioma's volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of blood lipid level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change of blood glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: evaluation of post-surgical associated complications
Endpoint domain: Adverse events/effects
Primary endpoint: change from baseline in urine protein-creatinine ratio (UPCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Diaphragmatic Dynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive β-hCG results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in perception of overall recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in self-reported function and health
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of patients with Treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with abnormal Physical examination data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with Nevi appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: QuickDASH (Disabilities of the Arm, Shoulder, and Hand) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PROMIS Bank v1.1 - Pain Interference Computer Adaptive Test
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: PROMIS Bank v2.0 - Upper Extremity Computer Adaptive Test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Insertion torque curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain control efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma pharmacokinetics of ZE50-0134
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health status related to COPD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in fecal incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Point of Subjective Equality (PSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot and ankle pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence rate of composite clinical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tolerance of escalating doses of ADSVF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Oral Intake Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Simplified Dysphagia Severity Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Eating Assessment Tool-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Emotional Wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time from positive nucleic acid to negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binary reading of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Anti-EV71 serum neutralizing antibody positive conversion rate at 28 days after immunization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titer (GMT) and growth factor of anti-EV71 serum neutralizing antibody 28 days after immunization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ratio of subjects with anti-EV71 serum neutralizing antibody titer ≥ 1:8 28 days after immunization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prefrontal theta oscillation activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change in overbite and overjet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of open bite closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Diabetes Distress (T1-DDS Total Score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Muscle thickness ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: DXA: total lean body mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DXA: appendicular skeletal muscle mass index (ASMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Diabetic Ketoacidosis (DKA) Admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate to Vigorous Physical Activity (MVPA) Amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minutes of Sleep per Day
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Gender
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ethnicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Potentially Clinically Significant Laboratory Abnormalities: Hematology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants With Potentially Clinically Significant Laboratory Abnormalities: Biochemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: overall response rate (ORR) cohort A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall response rate (ORR) cohort B
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Assessment Scale - upper extremity (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nine-Hole Peg Test (NHPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbopelvic Stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Spine Mobility and Alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Duration of latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ridge width reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metastatic lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Change from Baseline in basic psychological need satisfaction at work
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in Work motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in job and life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Structured Clinical Interview for DSM-5 (SCID-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Childhood Trauma Questionnaire (CTQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PICC care Knowledge scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Clinical Reasoning Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: POP symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline pain catastrophizing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in HAMD score during DBS treatment phase
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in HAMD scores during efficacy observation phase
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: KFR improvement using KDIGO AKI staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Subjects' perceived mental health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subject's perceived general health and well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subject's perceived skin health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lab biochemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vital signs - Heart Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vital signs - Blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vital signs - Temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Corneal Higher-Order Aberrations (HOAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Incidence of brain abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Women's Pain Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-month Overall Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Religious Coping Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Michel Uncertainty Scale in Illness-Community Form
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depression-Anxiety-Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of intoxication in paediatric children
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of intoxication in paediatric children
Endpoint domain: Mortality/survival
Primary endpoint: Changes in vaginal microbiome over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in vaginal pH over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of pre-malignant upper GI tract lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postoperative pain perception changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Romberg score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: INCAT Sensory Sum score (ISS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Prevalence of ADDwR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthcare use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: prevalence of persistent pelvic pain after TVT surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating TREM1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: sensitivity and specificity of hysteroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Blood Glucose Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic ability of anteroposterior LUS thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic decision
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Volume of affected arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of coronavirus vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of coronavirus vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Health-Related Quality of Life (HrQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Major Adverse Cardiovascular Events (MACE) free survival
Endpoint domain: Mortality/survival
Primary endpoint: BDAE Scale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: timing and time to care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: follow-up care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Enrolment from non-primary site
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Virtual session attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Outcome measure completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Identification of the Proportion of different metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Treatment-related adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of the STANDARD G6PD test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the STANDARD G6PD test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c of 7% or less
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Similarity of SpO2 readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Self-reported appropriate screening uptake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Aberrant Behavior Checklist-Irritability Scale (ABC-I)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sutter Eyberg Student Behavior Inventory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of major congenital malformations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants with Potentially Clinically Significant Vital Sign Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Achievement of ≥ 1-grade improvement from baseline on the investigator-rated clinician forehead lines Scale at maximum contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in serum levels of cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Degree of labor pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine cathepsin K proteins levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine cathepsin K activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in biomarker levels over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of involvement of patients in shared decision making
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Observed level of patient involvement in decision making according to the OPTION5 tool
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Sonographic Thigh Adjustment Ratio (STAR) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exhaled air concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Drusen Volume from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to Moderate Vision Loss
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Social distance desire
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Attitudes towards mental disorders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitudes towards disability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitudes towards homelessness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disclosure about mental disorders
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Key aspects of stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: rate of relinked HCV patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of relinked patients who received antiviral treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total analgesics consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Volume of parenteral nutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in activity of daily living (ADL) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of hospital-acquired respiratory viral infections
Endpoint domain: Adverse events/effects
Primary endpoint: relative sensitivity and specificity of urinary sampling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative sensitivity and specificity of vaginal self-sampling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: R0 surgical conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction of Hepatitis B virus DNA titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Absence of recourse to additional anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Behavioural functioning evaluated through the Strengths and Difficulties Questionnaire (SDQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Behavioural functioning evaluated through the Strengths and Weaknesses of ADHD Symptoms And Normal behaviour (SWAN) scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Healthcare resource utilisation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Select adverse clinical outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with HPV 6 or 11 infection in the pulmonary lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants with different mutational profiles in the matched laryngeal and pulmonary lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of sedation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with at least one on-treatment adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Concentration of insulin over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cmax of insulin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Tmax of insulin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AUC (area under the curve) of insulin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cognition as measured by ADAS-cog score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline Movement skills score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work role functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Family Functioning: Survey Measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Family Functioning: Direct Observation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plate Tapping Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cyberbullying Awareness Level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: anti-SARS-CoV-2 IgG Titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: neutralizing antibody titers in cord blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Level of expression of oxidative stress markers in the plasma and/or serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-meal Systolic Blood Pressure Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: GMT fold-rise for neutralizing antibodies D1 and D16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Photoplethysmography wave types
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes